Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516166 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

bioMérieux sa - SWOT Analysis

Datamonitor, May 2010, Pages: 24


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The bioMérieux sa - SWOT Analysis company profile is the essential source for top-level company data and information. bioMérieux sa - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

BioMerieux is a part of the Institut Merieux group. The company is engaged in providing in-vitro diagnostics for medical and industrial applications. The company designs, develops, manufactures and markets systems used in clinical applications, such as for the diagnosis of infectious diseases, and industrial applications, such as for the analysis of industrial or environmental samples. The company primarily operates in EMEA (Europe, Middle East and Africa), North America, Asia-Pacific and Latin America. It is headquartered in Marcy l'Etoile, France and employed 6,300 people as of December 2009. The company recorded revenues of E1,223.4 million (approximately $1,706.2 million) during the financial year (FY) ended December 2009, an increase of 10.2% over FY2008. The operating profit of the company was E203.7 million (approximately $284.1 million) during FY2009, an increase of 9.5% over FY2008. The net profit of the company was E147.8 million (approximately $206.1 million) in FY2009, an increase of 13.8% over FY2008.

Scope of the Report

- Provides all the crucial information on bioMérieux sa required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting bioMérieux sa in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of bioMérieux sa
-Data is supplemented with details on bioMérieux sa history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from bioMérieux sa

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



Customers who bought this item also bought

bioMerieux SA - SWOT Analysis

Biomerieux Sa Market Share Analysis

bioMerieux S.A. Market Share Analysis

bioMérieux sa - Strategy and SWOT Report

bioMerieux S.A. (BIM) - Financial and Strategic SWOT Analysis Review

bioMerieux S.A. (BIM) - Product Pipeline Analysis

bioMerieux S.A. Strategic Analysis Profile

Public Power Corporation S.A. - SWOT Analysis

AREVA SA - SWOT Analysis

Ubisoft Entertainment S.A. - SWOT Analysis



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds